
This issue we feature basic background information about the IIMHL leadership exchange and conference programme (Adobe Acrobat format). In particular we feature commentary about the success of the recent leadership exchange in Australia and New Zealand and the conference in Wellington, New Zealand. It makes great reading!
Tuesday, April 12, 2005
Friends and family first port of call for people with mental health problems Story at
Psychiatry Matters, based on an article published in the
British Journal of Psychiatry - "People with minor mental health problems are more likely to seek help from friends and family than from health professionals, reveal study findings that also show many people, particularly males, choose not to seek any form of help. ... 'People suffering from psychiatric symptoms, even if severe, often do not seek professional help,' observe Maria Isabel Oliver (Health Protection Agency South West, Gloucestershire) and colleagues. ... The researchers therefore sought to investigate whether patients with mental health problems, if not seeking help from their physician, are turning to other sources of help."
HMOs in Unstable Condition: Members Bolt to Other Plans Los Angeles Times story - "HMOs, once the top choice for Americans who get healthcare as a job perk, are so last century. Tightly controlled health maintenance organizations have steadily lost ground over the last decade to preferred provider organizations, which offer greater choice of physicians and hospitals and direct access to specialists — though at a higher price. HMOs garnered only 25% of the employer-based health benefits market last year, down from a high of 31% in 1996, according to a recent survey by the Kaiser Family Foundation... During the same period, PPOs nearly doubled their market share to 55%." [Viewing
Los Angeles Times stories requires registration, which is free].
Once too slow, FDA approvals called too fast... April 10
Boston Globe story - "Over 15 years, the Food and Drug Administration has swung from taking too long to get medicine to dying AIDS patients to drawing fire for rushing drugs to market that wound up killing people. The agency's troubles were highlighted last week, when it asked Pfizer Inc. to suspend sales of Bextra because the painkiller can cause fatal heart and skin problems. Bextra was the latest casualty in a drug safety controversy that began last fall with Vioxx, an arthritis drug quickly approved by the FDA and then taken off the market..."
FDA Calls for Warning on Antipsychotic Drugs Brief
Reuters story at
Yahoo - "The U.S. Food and Drug Administration on Monday ordered new warnings on antipsychotic drugs, alerting physicians to a higher death rate when the medicines are prescribed for atypical use of treating dementia in elderly patients. The black box warning affects Eli Lilly and Co.'s Zyprexa and Symbyax, AstraZeneca Pharmaceuticals LP's Seroquel, Johnson & Johnson's Risperdal, Novartis AG's Clozaril, Pfizer Inc.'s Geodon, and Bristol-Myers Squibb Co.'s and Otsuka America Pharmaceutical's Abilify. "
Copyright 2003 © Bill Davis.
IIMHL Update is a project done in collaboration with MHCA and
the Centre
for Community Change International. IIMHL Update is powered by Radio Userland.